Abstract
At this time, reactive arthritis (ReA) is considered to be part of the spectrum of the spondyloarthritis, previously known as Reiter’s syndrome, and refers to an infection induced systemic illness, characterized by a sterile synovitis occurring in a genetically predisposed individual, secondary to an infection localized in a distant organ/system, but also accompanied with multiple extra articular manifestations.
Similar content being viewed by others
References
Keynan Y, Rimar D (2008) Reactive arthritis—the appropriate name. Isr Med Assoc J 10(4):256–258
Panush R, Wallace D, Dorff R, Engleman E (2007) Retraction of the suggestion to use the term «Reiter’s syndrome» sixty-five years later. Arthritis Rheum 56(2):693–694. https://doi.org/10.1002/art.22374
Stavropoulos P, Soura E, Kanelleas A, Katsambas A, Antoniou C (2015) Reactive arthritis. J Eur Acad Dermatology Venereol 29(3):415–424. https://doi.org/10.1111/jdv.12741
Hannu T (2011) Reactive arthritis. Best Pract Res Clin Rheumatol 25(3):347–357. https://doi.org/10.1016/j.berh.2011.01.018
Colmegna I, Cuchacovich R, Espinoza L (2004) HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev 17(2):348–369. https://doi.org/10.1128/CMR.17.2.348
Gupta R, Misra R (2016) Microbe-triggered arthropathies: reactive arthritis and beyond. Int J Rheum Dis 19(5):437–439. https://doi.org/10.1111/1756-185X.12920
Lopez Férez F, García Novo E (1986) Tratados hipocráticos. (eds) Gredos, Madrid, España
Allison D (1980) Christopher Columbus: first case of Reiter’S disease in the old world? Lancet 316(8207):1309. https://doi.org/10.1016/S0140-6736(80)92381-8
Carter J, Hudson A (2009) Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin N Am 35(1):21–44. https://doi.org/10.1016/j.rdc.2009.03.010
Manasson J, Shen N, García H, Ubeda C, Iraheta I, Heguy A, Von Feldt J, Espinoza L, García Kutzbach A, Segal L, Ogdie A, Clemente J, Sher J (2017) Gut microbiota perturbations in reactive arthritis and post-infectious Spondyloarthritis arthritis. Rheum. https://doi.org/10.1002/art.40359 [Epub ahed of print]
Ehrenfeld M (2010) Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 9(5):A325–A329. https://doi.org/10.1016/j.autrev.2009.11.012
Szamocki S, Martyn-hemphill C, Green J (2016) Reactive arthritis: can’t see, can’t pee, can’t climb a tree. Trends Urol Men’s Heal 7(1):17–20. https://doi.org/10.1002/tre.501
García-Kutzbach A, Montenegro A, Iraheta I, Bará C, Saénz R (2011) Epidemiology of spondyloarthropathies in Central America. Am J Med Sci 341(4):295–297. https://doi.org/10.1097/MAJ.0b013e31820f8cf1
Brewerton D, Hart F, Nicholls A, Caffrey M, James D, Sturrock R (1973) Ankylosing spondylitis and HlA 27. Lancet 301(7809):904–907. https://doi.org/10.1016/S0140-6736(73)91360-3
Schlosstein L, Terasaki P, Bluestone R, Pearson C (1973) High association of an HLA antigen, W27 with ankylosing spondylitis. N Engl J Med 288(14):704–705. https://doi.org/10.1056/NEJM197304052881403
Vazquez-Torres A, Vallance B, Bergman M, Finlay B, Cookson B, Jones-Carson J et al (2004) Toll-like receptor 4 dependence of innate and adaptive immunity to salmonella: importance of the Kupffer cell network. J Immunol 172(10):6202–6208. https://doi.org/10.4049/jimmunol.172.10.6202
Reveille JD (2014) An update on the contribution of the MHC to as susceptibility. Clin Rheumatol 33(6):749–757. https://doi.org/10.1007/s10067-014-2662-7
Tsui F, Xi N, Rohekar S, Riarh R, Bilotta R, Tsui H et al (2008) Toll-like receptor 2 variants are associated with acute reactive arthritis. Arthritis Rheum 58(11):3436–3438. https://doi.org/10.1002/art.23967
Rihl M, Klos A, Köhler L, Kuipers J (2006) Reactive arthritis. Best Pract Res Clin Rheumatol 20(6):1119–1137. https://doi.org/10.1016/j.berh.2006.08.008
Denison H, Curtis E, Clynes M, Bromhead C, Dennison E, Grainger R (2016) The incidence of sexually acquired reactive arthritis: a systematic literature review. Clin Rheumatol 35(11):2639–2648. https://doi.org/10.1007/s10067-016-3364-0
Asquith M, Rosenbaum J (2016) The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathies. Curr Opin Rheumatol 28(4):405–412. https://doi.org/10.1097/BOR.0000000000000299
Reveille JD (2012) Genetics of spondyloarthritis—beyond the MHC. Nat Rev Rheumatol 8(5):296–304. https://doi.org/10.1038/nrrheum.2012.41
Pope J, Krizova A, Garg A, Thiessen-Philbrook H, Ouimet J (2007) Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 37(1):48–55. https://doi.org/10.1016/j.semarthrit.2006.12.006
Zeidler H, Hudson A (2016) Coinfection of chlamydiae and other bacteria in reactive arthritis and spondyloarthritis: need for future research. Microorganisms 4(3):30. https://doi.org/10.3390/microorganisms4030030
Carter J, Inman R (2011) Chlamydia-induced reactive arthritis: hidden in plain sight? Best Pract Res Clin Rheumatol 25(3):359–374. https://doi.org/10.1016/j.berh.2011.05.001
Gaston J (2005) Shigella induced reactive arthritis. Ann Rheum Dis 64(4):517–518. https://doi.org/10.1136/ard.2004.030395
Cargnelutti E, Di Genaro M (2013) Reactive arthritis: from clinical features to pathogenesis. Int J Clin Med 4(12):20–30. https://doi.org/10.4236/ijcm.2013.412A2004
Garcia H, Azan A, Iraheta I, Von Feldt J, Espinoza L, Manasson J, Scher J, García Kutzbach A (2017) Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up. Clin Rheumatol. https://doi.org/10.1007/s10067-017-3911.3 [Epub ahed of print]
Van de Wiele T, Van Praet J, Marzorati M, Drennan M, Elewaut D (2016) How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol 12(7):398–411. https://doi.org/10.1038/nrrheum.2016.85
Caminer A, Haberman R, Scher J (2017) Human microbiome, infections, and rheumatic disease. Clin Rheumatol 36(12):2645–2653. https://doi.org/10.1007/s10067-017-3875-3
Brown J, Hazen S (2015) The gut microbial endocrine organ: bacterially-derived signals driving cardiometabolic diseases. Annu Rev Med 66(1):343–359. https://doi.org/10.1146/annurev-med-060513-093205
Eckburg P, Bik E, Bernstein C, Purdom E, Dethlefsen L, Sargent M, Gill S, Nelson K, Relman D (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638. https://doi.org/10.1126/science.1110591
Blaser M, Bork P, Fraser C, Knight R, Wang J (2013) The microbiome explored: recent insights and future challenges. Nat Rev Microbiol 11(3):213–217. https://doi.org/10.1038/nrmicro2973
Catrina A, Deane K, Scher J (2016) Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis. Rheumatology 55(3):391–402. https://doi.org/10.1093/rheumatology/keu469
Wendling D, Prati C (2017) Spondyloarthritis: an expanding cast of cellular actors. Jt bone Spine:1–3. https://doi.org/10.1016/j.jbspin.2017.05
Ericsson A, Hagan C, Davis D, Franklin C (2014) Segmented filamentous bacteria: commensal microbes with potential effects on research. Comp Med 64(2):90–98
Ji B, Nielsen J (2015) New insight into the gut microbiome through metagenomics. Adv Genomics Genet 5:77–91. https://doi.org/10.2147/AGG.S57215
Ivanov I, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485–498. https://doi.org/10.1016/j.cell.2009.09.033
Miossec P (2017) Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice. RMD 3(1):e000284. https://doi.org/10.1136/rmdopen-2016-000284
Riente L, Sedie A, Filippucci E, Iagnocco A, Meenagh G, Grassi W, Valesini G, Bombardieri S (2007) Ultrasound imaging for the rheumatologist IX. Ultrasound imaging in spondyloarthritis. Clin Exp Rheumatol 25(3):349–353
Colmegna I, Espinoza L (2005) Recent advances in reactive arthritis. Curr Rheumatol Rep 7(3):201–207. https://doi.org/10.1007/s11926-996-0040-4
Allen-Vercoe E, Reid G, Viner N, Gloor G, Hota S, Kim P, Lee C, O’Doherty K, Vanner S, Weewe S, Petrof E (2012) A Canadian working group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol 26(7):457–462. https://doi.org/10.1155/2012/213828
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Abraham Garcia-Kutzbach: serve as Principal Investigator for clinical studies of Merck, Abbie, Novartis, and Janssen
Helga Garcia: Medical Scientific Liaison for Novartis Pharma Central America and Caribbean
Jose A. Chacon and Isa Iraheta do not report conflict of interest.
Rights and permissions
About this article
Cite this article
García-Kutzbach, A., Chacón-Súchite, J., García-Ferrer, H. et al. Reactive arthritis: update 2018. Clin Rheumatol 37, 869–874 (2018). https://doi.org/10.1007/s10067-018-4022-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-018-4022-5